about
Glycemic Variability: How Do We Measure It and Why Is It Important?Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetesWhite Matter Hyperintensity in Elderly Patients with Diabetes Mellitus Is Associated with Cognitive Impairment, Functional Disability, and a High Glycoalbumin/Glycohemoglobin Ratio.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?The glycated albumin to glycated hemoglobin ratio might not be associated with carotid atherosclerosis in patients with type 1 diabetes.Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetesAdvantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetesDiagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia.Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress.Glycemic control indicators in patients with neonatal diabetes mellitus.Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide.Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.Age-adjusted glycated albumin accurately reflects blood glucose in patients with neonatal diabetes mellitus: comparison with calculated glycated albumin determined by past blood glucose concentrations.A discrepancy between plasma glycated albumin and HbA1c levels in a patient with steroid-induced diabetes mellitus.Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.
P2860
Q26795377-7BCC5622-CFD2-4EBF-B774-9E2316F247C1Q28543379-E0403E27-8EFF-486D-9A1C-9219CF0FCE69Q33875382-1F7DF798-48D8-44D2-88B1-A4FA0F9D1A30Q34486820-EA956829-7D5F-43DE-8479-F4C98CC7246AQ34750061-4B863183-9E82-42CA-BC97-5F0A4FAA0FABQ35627229-4D881229-B935-41E3-ACD8-6201B2ED7CD0Q36159157-DEBA4F33-CD5E-486B-98BB-53B2057B7065Q36864306-EB46A261-1003-44CD-AA3F-C6E7A3E38A94Q36900001-D7F3E275-0F1B-4AE8-B450-B9A1607FA3A3Q37292095-219DEFF5-47D8-4517-A113-B1D772FF30BFQ37483905-FC62E709-F534-476F-AA07-5443FD2E03B2Q37708623-9BE00C77-96C3-45FF-8EBD-E44104A892F1Q41422572-090D02B7-9D70-4A19-A8FE-F732333DA2BDQ47711554-F2D2C49A-7B36-44C0-AA9D-B2BEDA2E08C4Q50445406-1EBF4059-8EE2-483C-BBFA-4F756878BCC7Q53872236-15E2D578-13BD-47A8-A6B7-3F063D808867Q55340247-03A2723C-E495-4E95-8ABE-979BDC9C1A7F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New indices for predicting glycaemic variability
@ast
New indices for predicting glycaemic variability
@en
New indices for predicting glycaemic variability
@nl
type
label
New indices for predicting glycaemic variability
@ast
New indices for predicting glycaemic variability
@en
New indices for predicting glycaemic variability
@nl
prefLabel
New indices for predicting glycaemic variability
@ast
New indices for predicting glycaemic variability
@en
New indices for predicting glycaemic variability
@nl
P2093
P2860
P1433
P1476
New indices for predicting glycaemic variability
@en
P2093
Akifumi Ogawa
Akihiro Takeuchi
Akinori Hayashi
Eriko Kishihara
Masayoshi Shichiri
Sonomi Yoshino
P2860
P304
P356
10.1371/JOURNAL.PONE.0046517
P407
P577
2012-09-27T00:00:00Z